EBIT at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's EBIT?
- Indivior Pharmaceuticals, Inc. (INDV) reported EBIT of $137M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's EBIT changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's EBIT increased by 107.6% year-over-year, from $66M to $137M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's EBIT?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's EBIT has grown at a 50.4% compound annual growth rate (CAGR), from -$77M to $262M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.